Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 77.35
-1.25 (-1.59%)
Jun 27, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 127.75 billion as of June 27, 2025. Its market cap has increased by 113.23% in one year.
Market Cap
127.75B
Enterprise Value
122.37B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
77.35
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 127.75B, an increase of 589.09%. That is a compound annual growth rate of 33.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 237.03B |
| Hansoh Pharmaceutical Group Company | 173.02B |
| JD Health International | 135.68B |
| WuXi Biologics | 101.72B |
| Sino Biopharmaceutical | 92.46B |
| CSPC Pharmaceutical Group | 89.38B |
| Akeso | 85.14B |
| Sichuan Kelun-Biotech Biopharmaceutical | 74.28B |